Howard Clowes
Director, Plus Therapeutics.
Companies
- Plus TherapeuticsBoard member Apr 2, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Plus Therapeutics CNSY1,981 shares2$3.4K at $1.70Jul 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Exercised options 922 shares of Plus Therapeutics2
- Sep 11, 2024Bought 5,000 shares at $1.34 of Plus Therapeutics3
- May 8, 2024Bought 9,804 shares at $2.04 of Plus Therapeutics4
- Sep 13, 2023Bought 6,993 shares at $1.43 of Plus Therapeutics5
- Jun 6, 2023Bought 1,000 shares at $3.98 of Plus Therapeutics6
- May 3, 2023Bought 2,500 shares at $3.64 of Plus Therapeutics7
- Jun 2, 2022Bought 15,000 shares at $0.57 of Plus Therapeutics8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPlus Therapeutics, Board member
- 2
- 3SEC EDGARForm 4 filed Sep 13, 2024
- 4SEC EDGARForm 4 filed May 10, 2024
- 5SEC EDGARForm 4 filed Sep 15, 2023
- 6SEC EDGARForm 4 filed Jun 8, 2023
- 7SEC EDGARForm 4 filed May 4, 2023
- 8SEC EDGARForm 4 filed Jun 6, 2022